Medical marijuana sales in Germany are projected to surpass €420 million (about $455.2 million) in 2024, with the market on track to hit €1 billion by 2028, according to the German Cannabis Report from Prohibition Partners, a London-based data firm.
The report highlights a 30% rise in medical marijuana sales in state-licensed pharmacies during the third quarter of 2023, with further growth following new laws implemented in April. Germany’s marijuana regulations, which allow for medical use and home growing of recreational marijuana, are some of the most progressive in Europe.
Since legalizing medical marijuana in 2017, Germany now has over 200,000 patients, and physicians can prescribe marijuana for any condition they deem appropriate. The country’s public health care system also reimburses patients for marijuana obtained from pharmacies.
The new Cannabis Act, effective since April, has further boosted the number of medical marijuana patients by removing previous restrictions. Although domestic production has expanded, Germany continues to rely on imports to meet demand, with imports reaching a record 11,705 kilograms in the second quarter of 2024.
